First salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi
Blood Cancer Journal, Published online: 11 December 2019; doi:10.1038/s41408-019-0265-xFirst salvage treatment with bendamustine and brentuximab vedotin in Hodgkin lymphoma: a phase 2 study of the Fondazione Italiana Linfomi (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 11, 2019 Category: Hematology Authors: A. Broccoli L. Argnani B. Botto P. Corradini A. Pinto A. Re U. Vitolo S. Fanti V. Stefoni P. L. Zinzani Source Type: research

Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma
Blood Cancer Journal, Published online: 11 December 2019; doi:10.1038/s41408-019-0264-yComprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 11, 2019 Category: Hematology Authors: Venkata Yellapantula Malin Hultcrantz Even H. Rustad Ester Wasserman Dory Londono Robert Cimera Amanda Ciardiello Heather Landau Theresia Akhlaghi Sham Mailankody Minal Patel Juan Santiago Medina-Martinez Juan Esteban Arango Ossa Max Fine Levine Niccolo B Source Type: research

Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN)
Blood Cancer Journal, Published online: 06 December 2019; doi:10.1038/s41408-019-0262-0Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 6, 2019 Category: Hematology Authors: Hannah C. Beird Maliha Khan Feng Wang Mansour Alfayez Tianyu Cai Li Zhao Joseph Khoury P. Andrew Futreal Marina Konopleva Naveen Pemmaraju Source Type: research

Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study
Blood Cancer Journal, Published online: 04 December 2019; doi:10.1038/s41408-019-0260-2Ofatumumab maintenance prolongs progression-free survival in relapsed chronic lymphocytic leukemia: final analysis of the PROLONG study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 4, 2019 Category: Hematology Authors: Marinus van Oers Lukas Smolej Mario Petrini Fritz Offner Sebastian Grosicki Mark-David Levin Jaclyn Davis Hiya Banerjee Tommaso Stefanelli Petra Hoever Christian Geisler Source Type: research

Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
Blood Cancer Journal, Published online: 03 December 2019; doi:10.1038/s41408-019-0261-1Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - December 3, 2019 Category: Hematology Authors: Nirav N. Shah Kwang Woo Ahn Carlos Litovich Anna Sureda Mohamed A. Kharfan-Dabaja Farrukh T. Awan Siddhartha Ganguly Usama Gergis David Inwards Reem Karmali Alexsandr Lazaryan Lazaros Lekakis Pashna Munshi Sunita Nathan Ayman A. Saad Melhem Solh Amir Stei Source Type: research

Characterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL
Blood Cancer Journal, Published online: 29 November 2019; doi:10.1038/s41408-019-0257-xCharacterization of novel, recurrent genomic rearrangements as sensitive MRD targets in childhood B-cell precursor ALL (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 29, 2019 Category: Hematology Authors: Udo zur Stadt Malik Alawi Manuela Adao Daniela Indenbirken Gabriele Escherich Martin A. Horstmann Source Type: research

Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma
Blood Cancer Journal, Published online: 28 November 2019; doi:10.1038/s41408-019-0259-8Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 28, 2019 Category: Hematology Authors: Jeffrey Wang Jacqueline Wang Elyse Lopez Hui Guo Hui Zhang Yang Liu Zhihong Chen Shengjian Huang Shouhao Zhou Angela Leeming R. J. Zhang Dayoung Jung Hannah Shi Hadley Grundman Darian Doakes Kathleen Cui Changying Jiang Makhdum Ahmed Krystle Nomie Binglia Source Type: research

Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone
Blood Cancer Journal, Published online: 25 November 2019; doi:10.1038/s41408-019-0254-0Gain of Chromosome 1q is associated with early progression in multiple myeloma patients treated with lenalidomide, bortezomib, and dexamethasone (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 25, 2019 Category: Hematology Authors: Timothy M. Schmidt Benjamin G. Barwick Nisha Joseph Leonard T. Heffner Craig C. Hofmeister Leon Bernal Madhav V. Dhodapkar Vikas A. Gupta David L. Jaye Jiayi Wu Subir Goyal Zhengjia Chen Lawrence H. Boise Sagar Lonial Ajay K. Nooka Jonathan L. Kaufman Source Type: research

Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia
Blood Cancer Journal, Published online: 25 November 2019; doi:10.1038/s41408-019-0258-9Expression of the long non-coding RNA TCL6 is associated with clinical outcome in pediatric B-cell acute lymphoblastic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 25, 2019 Category: Hematology Authors: Marta Cuadros Álvaro Andrades Isabel F. Coira Carlos Bali ñas Mar ía I. Rodríguez Juan Carlos Álvarez-Pérez Paola Peinado Alberto M. Arenas Daniel J. Garc ía Pilar Jim énez Mireia Cam ós Antonio Jim énez-Velasco Pedro P. Medina Source Type: research

Precise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma
Blood Cancer Journal, Published online: 21 November 2019; doi:10.1038/s41408-019-0256-yPrecise detection of genomic imbalances at single-cell resolution reveals intra-patient heterogeneity in Hodgkin’s lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 21, 2019 Category: Hematology Authors: Chiara Mangano Alberto Ferrarini Claudio Forcato Marianna Garonzi Paola Tononi Rossana Lanzellotto Andrea Raspadori Chiara Bolognesi Genny Buson Gianni Medoro Michael Hummel Francesca Fontana Nicol ò Manaresi Source Type: research

Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background
Blood Cancer Journal, Published online: 20 November 2019; doi:10.1038/s41408-019-0253-1Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 20, 2019 Category: Hematology Authors: Elizabeta A. Rojas Luis A. Corchete Mar ía Victoria Mateos Ram ón García-Sanz Irena Misiewicz-Krzeminska Norma C. Guti érrez Source Type: research

Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases
Blood Cancer Journal, Published online: 20 November 2019; doi:10.1038/s41408-019-0252-2Molecular switch from MYC to MYCN expression in MYC protein negative Burkitt lymphoma cases (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 20, 2019 Category: Hematology Authors: Lucia Mundo Maria Raffaella Ambrosio Francesco Raimondi Leonardo Del Porro Raffaella Guazzo Virginia Mancini Massimo Granai Bruno Jim Rocca Cristina Lopez Susanne Bens Noel Onyango Joshua Nyagol Nicholas Abinya Mohsen Navari Isaac Ndede Kirkita Patel Pier Source Type: research

In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019
Blood Cancer Journal, Published online: 19 November 2019; doi:10.1038/s41408-019-0250-4In response to: Treatment of patients with multiple myeloma progressing on frontline therapy with lenalidomide, Moreau et al., 2019 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 19, 2019 Category: Hematology Authors: Zandra Klippel Amy Kimball Christina Tekle Source Type: research

Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT
Blood Cancer Journal, Published online: 18 November 2019; doi:10.1038/s41408-019-0251-3Donor selection for a second allogeneic stem cell transplantation in AML patients relapsing after a first transplant: a study of the Acute Leukemia Working Party of EBMT (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 18, 2019 Category: Hematology Authors: Avichai Shimoni Myriam Labopin J ürgen Finke Fabio Ciceri Eric Deconinck Nicolaus Kr öger Martin Gramatzki Matthias Stelljes Didier Blaise Friedrich Stoelzel Patrice Chevallier Ernst Holler Nathalie Fegueux Mohamad Mohty Arnon Nagler Source Type: research

Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma
Blood Cancer Journal, Published online: 18 November 2019; doi:10.1038/s41408-019-0249-xMaternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 18, 2019 Category: Hematology Authors: Anke Maes Ken Maes Philip Vlummens Hendrik De Raeve Julie Devin Vanessa Szablewski Kim De Veirman Eline Menu Jerome Moreaux Karin Vanderkerken Elke De Bruyne Source Type: research

Prognostic impact of peripheral blood WT1-mRNA expression in patients with MDS
Blood Cancer Journal, Published online: 12 November 2019; doi:10.1038/s41408-019-0248-yPrognostic impact of peripheral blood WT1-mRNA expression in patients with MDS (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 12, 2019 Category: Hematology Authors: Christina Rautenberg Ulrich Germing Sabrina Pechtel Marius Lamers Carolin Fischermanns Paul J äger Stefanie Geyh Rainer Haas Guido Kobbe Thomas Schroeder Source Type: research

EASIX for prediction of survival in lower-risk myelodysplastic syndromes
Blood Cancer Journal, Published online: 11 November 2019; doi:10.1038/s41408-019-0247-zEASIX for prediction of survival in lower-risk myelodysplastic syndromes (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - November 11, 2019 Category: Hematology Authors: Almuth Merz Ulrich Germing Guido Kobbe Jennifer Kaivers Anna Jauch Aleksandar Radujkovic Manuela Hummel Axel Benner Maximilian Merz Peter Dreger Thomas Luft Source Type: research

SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma
Blood Cancer Journal, Published online: 14 October 2019; doi:10.1038/s41408-019-0246-0SIRPα expression delineates subsets of intratumoral monocyte/macrophages with different functional and prognostic impact in follicular lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 14, 2019 Category: Hematology Authors: Ya-Ping Chen Hyo Jin Kim Hongyan Wu Tammy Price-Troska Jose C. Villasboas Shahrzad Jalali Andrew L. Feldman Anne J. Novak Zhi-Zhang Yang Stephen M. Ansell Source Type: research

Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network
Blood Cancer Journal, Published online: 08 October 2019; doi:10.1038/s41408-019-0245-1Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)—a trial by the Asian Myeloma Network (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 8, 2019 Category: Hematology Authors: Cinnie Yentia Soekojo Kihyun Kim Shang-Yi Huang Chor-Sang Chim Naoki Takezako Hideki Asaoku Hideo Kimura Hiroshi Kosugi Junichi Sakamoto Sathish Kumar Gopalakrishnan Chandramouli Nagarajan Yuan Wei Rajesh Moorakonda Shu Ling Lee Je Jung Lee Sung-Soo Yoon Source Type: research

Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1
Blood Cancer Journal, Published online: 02 October 2019; doi:10.1038/s41408-019-0242-4Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 2, 2019 Category: Hematology Authors: Andrew B. Das Purvi M. Kakadia Damian Wojcik Lucy Pemberton Peter J. Browett Stefan K. Bohlander Margreet C. M. Vissers Source Type: research

A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1
Blood Cancer Journal, Published online: 01 October 2019; doi:10.1038/s41408-019-0244-2A novel machine-learning-derived genetic score correlates with measurable residual disease and is highly predictive of outcome in acute myeloid leukemia with mutated NPM1 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 1, 2019 Category: Hematology Authors: Nikhil Patkar Anam Fatima Shaikh Chinmayee Kakirde Shrinidhi Nathany Hridya Ramesh Prasanna Bhanshe Swapnali Joshi Shruti Chaudhary Sadhana Kannan Syed Hasan Khizer Gaurav Chatterjee Prashant Tembhare Dhanalaxmi Shetty Anant Gokarn Sachin Punatkar Avinash Source Type: research

Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion
Blood Cancer Journal, Published online: 01 October 2019; doi:10.1038/s41408-019-0239-zCharacterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 1, 2019 Category: Hematology Authors: Ross A. Rowsey Stephanie A. Smoley Cynthia M. Williamson George Vasmatzis James B. Smadbeck Yi Ning Patricia T. Greipp Nicole L. Hoppman Linda B. Baughn Rhett P. Ketterling Jess F. Peterson Source Type: research

A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma
Blood Cancer Journal, Published online: 01 October 2019; doi:10.1038/s41408-019-0240-6A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - October 1, 2019 Category: Hematology Authors: Hans C. Lee Jatin J. Shah Lei Feng Elisabet E. Manasanch Rebecca Lu Ashley Morphey Brandon Crumpton Krina K. Patel Michael L. Wang Raymond Alexanian Sheeba K. Thomas Donna M. Weber Robert Z. Orlowski Source Type: research

Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma
Blood Cancer Journal, Published online: 30 September 2019; doi:10.1038/s41408-019-0238-0Ultradeep, targeted sequencing reveals distinct mutations in blood compared to matched bone marrow among patients with multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 30, 2019 Category: Hematology Authors: David G. Coffey Qian V. Wu Andrea M. H. Towlerton Sharon Ornelas Alicia J. Morales Yuexin Xu Damian J. Green Edus H. Warren Source Type: research

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia
Blood Cancer Journal, Published online: 30 September 2019; doi:10.1038/s41408-019-0237-1Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 30, 2019 Category: Hematology Authors: Vivek Kumar Sikander Ailawadhi Leyla Bojanini Aditya Mehta Suman Biswas Taimur Sher Vivek Roy Prakash Vishnu Julian Marin-Acevedo Victoria R. Alegria Aneel Paulus Sonikpreet Aulakh Madiha Iqbal Rami Manochakian Winston Tan Asher Chanan-Khan Meghna Ailawad Source Type: research

The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients
Blood Cancer Journal, Published online: 30 September 2019; doi:10.1038/s41408-019-0241-5The ATRA-21 gene-expression model predicts retinoid sensitivity in CEBPA double mutant, t(8;21) and inv(16) AML patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 30, 2019 Category: Hematology Authors: Marco Bolis Mineko Terao Linda Pattini Enrico Garattini Maddalena Fratelli Source Type: research

Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia
Blood Cancer Journal, Published online: 30 September 2019; doi:10.1038/s41408-019-0243-3Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 30, 2019 Category: Hematology Authors: Adri án Mosquera Orgueira Beatriz Antelo Rodr íguez Jos é Ángel Díaz Arias Jos é Luis Bello López Source Type: research

Myelofibrosis in 2019: moving beyond JAK2 inhibition
Blood Cancer Journal, Published online: 11 September 2019; doi:10.1038/s41408-019-0236-2Myelofibrosis in 2019: moving beyond JAK2 inhibition (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - September 11, 2019 Category: Hematology Authors: Michael Schieber John D. Crispino Brady Stein Source Type: research

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma
Blood Cancer Journal, Published online: 30 August 2019; doi:10.1038/s41408-019-0233-5Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 30, 2019 Category: Hematology Authors: Yucai Wang Kerstin Wenzl Michelle K. Manske Yan W. Asmann Vivekananda Sarangi Patricia T. Greipp Jordan E. Krull Keenan Hartert Rong He Andrew L. Feldman Matthew J. Maurer Susan L. Slager Grzegorz S. Nowakowski Thomas M. Habermann Thomas E. Witzig Brian K Source Type: research

Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies
Blood Cancer Journal, Published online: 28 August 2019; doi:10.1038/s41408-019-0234-4Mass cytometry dissects T cell heterogeneity in the immune tumor microenvironment of common dysproteinemias at diagnosis and after first line therapies (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 28, 2019 Category: Hematology Authors: Taxiarchis V. Kourelis Jose C. Villasboas Erik Jessen Surendra Dasari Angela Dispenzieri Dragan Jevremovic Shaji Kumar Source Type: research

Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma
Blood Cancer Journal, Published online: 27 August 2019; doi:10.1038/s41408-019-0235-3Cystic transformation of focal lesions after therapy is associated with remission but adverse outcome in myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 27, 2019 Category: Hematology Authors: Maximilian Merz Thomas Hielscher Elias Karl Mai Anja Seckinger Dirk Hose Anna Jauch Sandra Sauer Steffen Luntz Uta Bertsch Marc S. Raab Kai Neben Hans Salwender Igor W. Blau Hans-Walter Lindemann Jan D ürig Christof Scheid Mathias Haenel Katja Weisel Tim Source Type: research

Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)
Blood Cancer Journal, Published online: 27 August 2019; doi:10.1038/s41408-019-0228-2Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 27, 2019 Category: Hematology Authors: F. Hitz M. Kraus T. Pabst D. Hess L. Besse T. Silzle U. Novak K. Seipel S. Rondeau S. St üdeli S. Berardi Vilei P. Samaras U. Mey C. Driessen Source Type: research

Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse
Blood Cancer Journal, Published online: 21 August 2019; doi:10.1038/s41408-019-0229-1Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 21, 2019 Category: Hematology Authors: Jiao Ma David Redmond Ayako Miyaguchi Anna S. Nam Kui Nie Susan Mathew Olivier Elemento Wayne Tam Source Type: research

Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy
Blood Cancer Journal, Published online: 20 August 2019; doi:10.1038/s41408-019-0227-3Inhibition of E-Selectin (GMI-1271) or E-selectin together with CXCR4 (GMI-1359) re-sensitizes multiple myeloma to therapy (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 20, 2019 Category: Hematology Authors: Barbara Muz Feda Azab Mark Fiala Justin King Daniel Kohnen William E. Fogler Ted Smith John L. Magnani Ravi Vij Abdel Kareem Azab Source Type: research

Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome
Blood Cancer Journal, Published online: 19 August 2019; doi:10.1038/s41408-019-0230-8Molecular characteristics of diffuse large B-cell lymphoma in the Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin lymphomas (PETAL) trial: correlation with interim PET and outcome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 19, 2019 Category: Hematology Authors: Julia Richter Andreas H üttmann Jan Rekowski Christine Schmitz Selina G ärtner Andreas Rosenwald Martin-Leo Hansmann Sylvia Hartmann Peter M öller Hans-Heinrich Wacker Alfred Feller Christoph Thorns Stefan M üller Ulrich D ührsen Wolfram Klapper Source Type: research

Oprozomib in patients with newly diagnosed multiple myeloma
Blood Cancer Journal, Published online: 16 August 2019; doi:10.1038/s41408-019-0232-6Oprozomib in patients with newly diagnosed multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 16, 2019 Category: Hematology Authors: Parameswaran Hari Jeffrey V. Matous Peter M. Voorhees Kenneth H. Shain Mihaela Obreja John Frye Hisaki Fujii Andrzej J. Jakubowiak Davide Rossi Pieter Sonneveld Source Type: research

Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia
Blood Cancer Journal, Published online: 16 August 2019; doi:10.1038/s41408-019-0231-7Practical limitations of monocyte subset repartitioning by multiparametric flow cytometry in chronic myelomonocytic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 16, 2019 Category: Hematology Authors: Prateek A. Pophali Michael M. Timm Abhishek A. Mangaonkar Min Shi Kaaren Reichard Ayalew Tefferi Kevin Pavelko Jose C. Villasboas Dragan Jevremovic Mrinal M. Patnaik Source Type: research

Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunity
Blood Cancer Journal, Published online: 12 August 2019; doi:10.1038/s41408-019-0224-6Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunity (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 12, 2019 Category: Hematology Authors: Arghya Ray Yan Song Dharminder Chauhan Kenneth C. Anderson Source Type: research

An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome
Blood Cancer Journal, Published online: 09 August 2019; doi:10.1038/s41408-019-0226-4An acquired high-risk chromosome instability phenotype in multiple myeloma: Jumping 1q Syndrome (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 9, 2019 Category: Hematology Authors: Jeffrey R. Sawyer Erming Tian Brian A. Walker Christopher Wardell Janet L. Lukacs Gael Sammartino Clyde Bailey Carolina D. Schinke Sharmilan Thanendrarajan Faith E. Davies Gareth J. Morgan Bart Barlogie Maurizio Zangari Frits van Rhee Source Type: research

Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients
Blood Cancer Journal, Published online: 09 August 2019; doi:10.1038/s41408-019-0223-7Lymphopenia at diagnosis is highly prevalent in myelodysplastic syndromes and has an independent negative prognostic value in IPSS-R-low-risk patients (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 9, 2019 Category: Hematology Authors: Tobias Silzle Sabine Blum Esther Schuler Jennifer Kaivers Martina Rudelius Barbara Hildebrandt Norbert Gattermann Rainer Haas Ulrich Germing Source Type: research

Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Blood Cancer Journal, Published online: 08 August 2019; doi:10.1038/s41408-019-0225-5Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 8, 2019 Category: Hematology Authors: Tiziano Barbui Valerio De Stefano Anna Falanga Guido Finazzi Ida Martinelli Francesco Rodeghiero Alessandro M. Vannucchi Giovanni Barosi Source Type: research

Mutational processes contributing to the development of multiple myeloma
Blood Cancer Journal, Published online: 06 August 2019; doi:10.1038/s41408-019-0221-9Mutational processes contributing to the development of multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 6, 2019 Category: Hematology Authors: Phuc H. Hoang Alex J. Cornish Sara E. Dobbins Martin Kaiser Richard S. Houlston Source Type: research

Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis
Blood Cancer Journal, Published online: 05 August 2019; doi:10.1038/s41408-019-0220-xAssociation of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - August 5, 2019 Category: Hematology Authors: Alyssa I. Clay-Gilmour Abdul R. Rishi Lynn R. Goldin Alexandra J. Greenberg-Worisek Sara J. Achenbach Kari G. Rabe Matthew J. Maurer Neil E. Kay Tait D. Shanafelt Timothy G. Call J. Brice Weinberg Nicola J. Camp James R. Cerhan Jose Leis Aaron Norman Davi Source Type: research

A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma
Blood Cancer Journal, Published online: 31 July 2019; doi:10.1038/s41408-019-0217-5A preliminary study of the anti-κ myeloma antigen monoclonal antibody KappaMab (MDX-1097) in pretreated patients with κ-restricted multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 31, 2019 Category: Hematology Authors: Andrew Spencer Patricia Walker Parisa Asvadi Douglas H. Campbell Kate Reed Ben R. Herbert Edmond J. Breen Michael C. Copeman Rosanne D. Dunn Source Type: research

Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden
Blood Cancer Journal, Published online: 30 July 2019; doi:10.1038/s41408-019-0222-8Sequence variation at the MTHFD1L-AKAP12 and FOPNL loci does not influence multiple myeloma survival in Sweden (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 30, 2019 Category: Hematology Authors: Mina Ali Konstantinos Lemonakis Anna-Karin Wihlborg Ljupco Veskovski Ingemar Turesson Ulf-Henrik Mellqvist Urban Gullberg Markus Hansson Bj örn Nilsson Source Type: research

Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma
Blood Cancer Journal, Published online: 29 July 2019; doi:10.1038/s41408-019-0219-3Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 29, 2019 Category: Hematology Authors: Binod Dhakal Anita D ’Souza Mehdi Hamadani Carlos Arce-Lara Katrina Schroeder Saurabh Chhabra Nirav N. Shah Katelyn Gauger Taylor Keaton Marcelo Pasquini Parameswaran Hari Source Type: research

RIP sequencing in mantle cell lymphoma identifies functional long non-coding RNAs associated with translation machinery
Blood Cancer Journal, Published online: 26 July 2019; doi:10.1038/s41408-019-0216-6RIP sequencing in mantle cell lymphoma identifies functional long non-coding RNAs associated with translation machinery (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 26, 2019 Category: Hematology Authors: Guangzhen Hu Yuji Zhang Mamta Gupta Source Type: research

Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia
Blood Cancer Journal, Published online: 25 July 2019; doi:10.1038/s41408-019-0214-8Correction: The ALK inhibitor AZD3463 effectively inhibits growth of sorafenib-resistant acute myeloid leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - July 25, 2019 Category: Hematology Authors: Sausan A. Moharram Kinjal Shah Fatima Khanum Lars R önnstrand Julhash U. Kazi Source Type: research

Correction: Waldenström macroglobulinemia treatment algorithm 2018
Blood Cancer Journal, Published online: 25 June 2019; doi:10.1038/s41408-019-0212-xCorrection: Waldenström macroglobulinemia treatment algorithm 2018 (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 25, 2019 Category: Hematology Authors: Morie A. Gertz Source Type: research

Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas
Blood Cancer Journal, Published online: 17 June 2019; doi:10.1038/s41408-019-0213-9Immunoglobulin gene rearrangement IGHV3-48 is a predictive marker of histological transformation into aggressive lymphoma in follicular lymphomas (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - June 17, 2019 Category: Hematology Authors: Mar ía García-Álvarez Sara Alonso- Álvarez Isabel Prieto-Conde Cristina Jim énez M. Eugenia Sarasquete M. Carmen Chill ón Alejandro Medina Ana Balanzategui Rebeca Maldonado Alicia Ant ón Noem í Puig Marta Rodr íguez Oscar Blanco Pilar Tamayo Ver Source Type: research